The American Society for Clinical Pathology (ASCP) has selected Shiwen Song, MD, PhD, as ASCP Senior Scientific Director. The Chicago-based society selected Song for this role as the association strengthens its scientific and evidence-based approach to serving members, and ultimately, the patient.
Song came to ASCP from Long Island Pathology in New York, where he was attending pathologist. His extensive clinical and research background includes surgical/gastrointestinal pathology fellowship training at University of Southern California (USC) in Los Angeles, anatomic and clinical pathology residency training at USC and Cook County Hospital in Chicago, and assistant professor working on cancer research at Rush Cancer Institute of Rush University Medical Center in Chicago. After he received his MD degree, he earned a PhD in molecular cardiology at Beijing Medical University.
Song will be responsible for the vision, direction, focus, and management for the scientific and educational activities of the ASCP. He will also identify cross-functional issues affecting, or deriving from, all clinical laboratory areas, and conduct scientific inquiry into all ASCP products and services. Song will also provide scientific guidance to support the Washington, DC, office.
“ASCP is an excellent society on behalf of patients, pathologists, scientists, and laboratory professionals, and I want to assist in its mission to provide excellence in education, certification and advocacy,” Song said. “We must ensure that ASCP uses the best data and best science when determining which products are most important for our patients and our profession.”
Song began his appointment with ASCP on November 11, 2010.
Source: ASCP
